|
Which would you
choose? Surgery or No surgery? I don't know about you but, I am
choosing NO SURGERY!
Market Update
News presents,
Rapid
Recovery Health Services Inc.
**RPRV**
Major Breaking Back to Back news was
released,
Rapid Recovery Updates Revenue Guidance, increasing net sales to
$8,000,000 for 2005,
and then this came
out,
Rapid Recovery Health Services is proud to announce that
Dr. Anders Cohen been named a Clinical
Director
(Go to any financial such as yahoo to read both of these
news releases now)
Aggressive investors
and day traders may be excited about Rapid Recovery Health Services Inc. (Other
OTC:RPRV.PK) right now. Back to back news has
been released. Because of that we are issuing a strong watch
alert for RPRV.
Points to
ponder,
It doesn't take a
rocket scientist to figure this one out. Just say your Dr has just
informed you that you need an operation to fix your ailement and relieve you of
horrible pain. The next day you go to get a second opinion and that Dr
says you don't need surgery, there is a new treatment that will fix your problem
and aleviate your pain. Which would you choose? Surgery or No
surgery? I don't know about you but I am choosing NO SURGERY! Read
on,
Extracorporeal Shock Wave Therapy, or
ESWT, is an innovative, non-surgical method developed for the treatment
of localized musculoskeletal pain. Since the early 1990s, investigators have
studied the use of shock waves for the treatment of painful musculoskeletal
disorders. ESWT is a treatment designed to treat tendonapothies throughout the
body that would otherwise require surgical treatment.
Rapid Recovery Health Services has established a
mobile ESWT Program that contracts with over 600 physicians in the NY-NJ-CT
Tri-State area and is the exclusive source for low energy ESWT treatment.
The mobile program is currently generating in excess of $250,000 in
monthly revenue with five systems providing treatment.
Based on the demographics of our national
population, wide-spread historical statistics on tendon-related ailments and
coverage from insurance carriers, the Company conservatively estimates there is
a market demand for over 15 million treatments per year. This figure represents
approximately 10% of the existing surgical markets of patients with insurance
coverage that pays for ESWT
Based on the current mix of insurance payers, with
as little as a 10% market penetration into the existing surgical market for
patients suffering from tendonapothies, there is a market for 1.25 million
procedures per month. The Company sees this figure increasing by 300% - 500%
over the next 18 - 36 months as more insurance carriers begin to initiate
coverage for ESWT.
ESWT is associated with short recovery time, low
cost, ease and relative low risk of complications makes this an attractive
alternative for many people with chronic lateral epicondylitis and plantar
fasciitis. ESWT is fast and non-invasive.
Yahoo! Groups Links
| ||||||||||||||
